广泛性焦虑障碍行为激活与暴露治疗反应多水平预测的随机对照试验方案
该随机对照试验纳入广泛性焦虑障碍患者,比较10周团体暴露治疗与行为激活治疗,并在治疗前后进行行为、生物标志物和神经影像评估。主要分析用混合模型检验基线趋近-回避行为及相关神经反应是否调节GAD-7症状变化,探索性分析用数据降维和机器学习方法。
要点
- 仅40-60%广泛性焦虑障碍患者从金标准心理社会干预中获得持久改善。
- 试验比较10周团体暴露治疗与行为激活治疗,聚焦威胁与奖赏加工。
- 基线趋近、回避和冲突仲裁行为及神经反应将检验是否调节GAD-7症状变化。
核心结论
- 该方案旨在确定趋近-回避行为及相关神经反应是否调节广泛性焦虑障碍对暴露治疗与行为激活治疗的反应。
研究设计与样本
- 随机对照试验,比较两种10周团体干预:暴露治疗或行为激活治疗。
- 治疗前后对参与者进行访谈及行为、生物标志物和神经影像评估,聚焦趋近回避加工与决策。
主要发现
- 原文未报告试验结果。
关键数值与推荐
- 主要分析使用混合模型检验基线假设的趋近、回避和冲突仲裁行为及相关神经反应是否调节GAD-7评估的症状变化。
- 探索性分析检验其他潜在治疗调节因素,并使用数据降维和机器学习方法。
临床怎么用
- 该方案为向神经科学知情和个性化心理社会治疗推进提供研究设计框架。
- 结果将对广泛性焦虑障碍的趋近-回避加工、分析水平间关系及行为治疗结局预测因素提供启示。
局限性
- 该研究为方案,尚未报告结果。
- 试验为回顾性注册,在首例参与者入组后21天内完成注册。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Only 40-60% of patients with generalized anxiety disorder experience long-lasting improvement with gold standard psychosocial interventions. Identifying neurobehavioral factors that predict treatment success might provide specific targets for more individualized interventions, fostering more optimal outcomes and bringing us closer to the goal of "personalized medicine." Research suggests that reward and threat processing (approach/avoidance behavior) and cognitive control may be important for understanding anxiety and comorbid depressive disorders and may have relevance to treatment outcomes. This study was designed to determine whether approach-avoidance behaviors and associated neural responses moderate treatment response to exposure-based versus behavioral activation therapy for generalized anxiety disorder. METHODS/DESIGN: We are conducting a randomized controlled trial involving two 10-week group-based interventions: exposure-based therapy or behavioral activation therapy. These interventions focus on specific and unique aspects of threat and reward processing, respectively. Prior to and after treatment, participants are interviewed and undergo behavioral, biomarker, and neuroimaging assessments, with a focus on approach and avoidance processing and decision-making. Primary analyses will use mixed models to examine whether hypothesized approach, avoidance, and conflict arbitration behaviors and associated neural responses at baseline moderate symptom change with treatment, as assessed using the Generalized Anxiety Disorder-7 item scale. Exploratory analyses will examine additional potential treatment moderators and use data reduction and machine learning methods. DISCUSSION: This protocol provides a framework for how studies may be designed to move the field toward neuroscience-informed and personalized psychosocial treatments. The results of this trial will have implications for approach-avoidance processing in generalized anxiety disorder, relationships between levels of analysis (i.e., behavioral, neural), and predictors of behavioral therapy outcome. TRIAL REGISTRATION: The study was retrospectively registered within 21 days of first participant enrollment in accordance with FDAAA 801 with ClinicalTrials.gov, NCT02807480. Registered on June 21, 2016, before results.
引用
- Santiago J, Akeman E, Kirlic N, et al. Protocol for a randomized controlled trial examining multilevel prediction of response to behavioral activation and exposure-based therapy for generalized anxiety disorder. Trials. 2020. PMID: 31907032. doi:10.1186/s13063-019-3802-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。